SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

Treasure Global (TGL) is trending due to a massive price surge following a reverse stock split, with community members drawing comparisons to SMX's previous run. The stock's low float and potential short squeeze are fueling discussions about continued momentum, with some traders setting ambitious price targets. However, there's also caution, with some posts warning of a potential pullback.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending, with community members actively discussing potential breakouts and accumulation strategies around the current price levels. Some are comparing Litecoin's chart to that of other cryptocurrencies and even Nvidia, while others point to its established infrastructure and transactional utility as reasons for long-term bullishness. Chatter revolves around potential golden crosses and the impact of Bitcoin dominance on Litecoin's price action.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana's stock is trending amidst community discussions about its potential S&P 500 inclusion and its incredible recovery from near zero, with some questioning the company's business model and financial health. There are debates around whether the stock is overvalued, with some expecting a rise while others anticipate a correction or short opportunity. Discussions also highlight the high level of short interest and potential for manipulation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid news of its acquisition of Warner Bros. Discovery, a move sparking debate about its impact on competition and debt. Community discussions revolve around the potential for regulatory challenges, the deal's long-term value, and concerns about debt and market dominance, with some seeing it as a strategic win and others as a risky, overleveraged play.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to a surge in after-hours activity and positive profit outlook for FY2025. The community is discussing its low float, potential for a short squeeze, and comparing it to other recent runners like $TGL and $SMX. Some traders are expressing caution due to its history and connection to Hong Kong-based companies.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as the community discusses potential ecosystem rebuilding, token burns, and impacts from exchange platform upgrades. Some investors are optimistic about a comeback, drawing parallels to other cryptocurrencies that recovered from regulatory challenges, while others remain skeptical, citing the token's history and supply. Court cases are also creating demand and buying volume.

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MetaVia Inc.

MetaVia ($MTVA) is trending due to positive signals from technical analysis and AI platforms, sparking community discussion about its potential for upward momentum. Some traders are highlighting the stock's low float and comparing it to other recent runners, while others debate whether to hold positions into the next week. The community is actively sharing their perspectives and insights on MTVA's next move, anticipating a possible breakout.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as the company plans to submit PDUFA after SOL 1 readout, moving up the timeline and exciting investors. The community is discussing the potential risks and rewards of this move, with some speculating about future stock price impact. Some believe this shows confidence from leadership, while others see it as a move to prevent a cheap buyout.

Gulf Resources, Inc. is a holding company that engages in the manufacture of chemical products. It operates through the following segments: Bromine, Crude Salt, Chemical Products, and Natural Gas. It produces and trades bromine, crude salt and natural gas, and manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, and oil field drilling. The firm also supplies papermaking chemical agents, inorganic chemicals, and manufactures materials for human and animal antibiotics. The company was founded by Ming Yang on February 28, 1989 and is headquartered in Shouguang, China.

Gulf Resources Inc

Gulf Resources (GURE) is trending due to recent gains and high social media interest, with community members pointing to its low float and potential for a short squeeze. Some traders are highlighting positive financial metrics and potential catalysts related to bromine prices and new acquisitions. However, some users are warning about the stock's history and potential for volatility.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

CVKD is trending as investors focus on its low float and potential breakout, particularly highlighting bullish technical indicators. Community members are actively discussing the stock's momentum and setup, with some pointing to a recent Zacks Small-Cap Research Report featuring a price target. The company's focus on a catalyst-driven, low-float healthcare microcap is also a key talking point.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ocular Therapeutix (NASDAQ:OCUL) Trading Up 12.3% - What's Next?

Ocular Therapeutix (NASDAQ:OCUL) Shares Up 12.3% - Here's What Happened...

Intech Investment Management LLC Sells 22,361 Shares of Ocular Therapeutix, Inc. $OCUL

Intech Investment Management LLC lessened its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 19.7% during the second quarter, according to the company in its most recent 13F...

Ocular Therapeutix (NASDAQ:OCUL) Earns "Buy" Rating from HC Wainwright

HC Wainwright restated a "buy" rating and issued a $19.00 price target on shares of Ocular Therapeutix in a research report on Tuesday...

Ocular Therapeutix (NASDAQ:OCUL) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen upgraded shares of Ocular Therapeutix from a "sell" rating to a "hold" rating in a research report on Monday...

Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet

The consensus price target hints at an 82.5% upside potential for Ocular Therapeutix (OCUL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) have received a consensus rating of "Moderate Buy" from the fourteen analysts that are covering the stock, MarketBeat.com reports...

Ocular Therapeutix (NASDAQ:OCUL) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen lowered Ocular Therapeutix from a "hold" rating to a "sell" rating in a report on Sunday...

Chardan Capital Issues Optimistic Forecast for OCUL Earnings

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) - Stock analysts at Chardan Capital lifted their FY2025 earnings estimates for Ocular Therapeutix in a note issued to investors on Wednesday...

Y Intercept Hong Kong Ltd Buys New Holdings in Ocular Therapeutix, Inc. $OCUL

Y Intercept Hong Kong Ltd purchased a new position in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) in the 2nd quarter, according to the company in its most recent filing with the...

HC Wainwright Cuts Earnings Estimates for Ocular Therapeutix

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) - Equities research analysts at HC Wainwright reduced their Q4 2025 earnings per share (EPS) estimates for Ocular Therapeutix in a report issued...

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.32	--	--	N/A
Q3 '25	-$0.37	-$0.38	-2.28%	MISSED
Q2 '25	-$0.35	-$0.39	-10.28%	MISSED
Q1 '25	-$0.29	-$0.38	-29.08%	MISSED
Q4 '24	-$0.27	-$0.29	-8.64%	MISSED

OCUL
Ocular Therapeutix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest OCUL News

OCULOcular Therapeutix Inc